Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

center * chemokines 29

12th World AIDS Conference

-Keyword

Abstract

n a public AIDS referral in Sao Paulo, Brazil/Evaluation of t
load mean in the same before and after implementation of t
community and migrant centers: Prevention of HIV perinatal trans
wo large urban medical /Antiretroviral prophylaxis of occu
on STD/AIDS/Itinerant for HIV/AIDS anonymous testing (
on of HIV/AIDS drop-in as an effective service delivery mo
AIDS epidemic/Drop-in in Montreal: Adaptation to the AID
HIV detection in French of anonymous and free detection/
esources scarcity? A Central-African country experience, Dem

d normal population of Central
c subtypes in West and
berculosis unit, Douala
ty sample of North and
among STD patients in
ars prospective survey/
f a prospective study/
ndividuals in Honduras,
an HIV infected patient/
gramme for West and
nd AIDS among recent
rspective in Honduras,
ccal infections at Mpilo
DS patients at Wellesley
nd control in Honduras,

Europe/Frequency of the A32 del
Africa/Molecular epidemiology of
Hospital/Seroepidemiology of HIV
Trinidad, WI: Results from the volu
African Republic/Bacterial vagino
venous catheters (CVC)-related b
venous catheter infections in AIDS
America, 1996/HIV subtyping and
nervous system infection by protot
Africa (German Technical Corpora
and South American immigrants in
America/The construction of a leg
Hospital, Bulawayo, Zimbabwe/Pr
Hospital/Chiropractic care for HIV
America/Construction of local net

sistant tuberculosis in a central Lisbon hospital/Comparing RFLP I
he diagnosis of primary nervous system lymphoma (PCNS
ent with AIDS/Primary nervous system lymphoma with ne
ent/Tuberculosis of the nervous system in HIV infected pat
ex workers (women) in Calcutta, for preventive interventio
and rickshaw pullers of Calcutta/Role of peer educators in
nalysis transported to a clinical trials laboratory/Color met
management course for level and mid-level managers/ST
s (HIV)/Co-infection of nervous system by gram negative
ntion among gay men in London gyms/Recruiting peer edu
ing anabolic steroids in London gyms/Injecting behaviour
t the AIDS Information Centre (AIC) in Kampala, Uganda/HIV dis
lustration with the SAS (for Solidarity and Social Action) in
at the AIDS Information, Uganda/Performance of a rapid H
V/AIDS patients/AIDS of West Bohemia and its goals in th
um (KANCO) Resource using participatory methods/Evalu
nding STD Counselling at Government General Hospital (
isiting their local health centre in Lusaka, Zambia?/Why do peopl
of the AIDS information, Uganda/Community outreach and
SF) in an HIV treatment: CSF initiation modalities and impa
cal tertiary HIV referral - Impact on hospital and communit
eening and counselling in Budapest, Hungary/Evaluation o
nd model counselling - A pilot project/Voluntary HIV testi
selling and testing (CT) in Uganda/HIV risk characteristics f
ng at an AIDS research in Uganda/Helpline telephone and f
sidential Rehabilitation Centres in France, 1993-97/HIV and HCV
aternal and child health centres /Impact evaluation of targeted trai

60754
60992
23294
33178
33322
34123
34288
60769
60962
11108
430*/11163
13120
13165
13284
22106
22120
22206
32213
43224
43413
44121
60282
60661
60973
13203
22291
22299
32214
33345
33441
42205
43526
60605
60810
60811
23166
34185
135*/43109
60194
60218
60890
22133
33344
42436
42450
43150
60139
60726
60956
23201
13478

-- Keyword Abstrai
ion in patients with HIV/ Cerebrovascular autoregulation in patient
D clinics in Pune, India/ Cervical intraepithelial changes and HIV in
women in Los Angeles/ dysplasia progression rates over
men with HIV infection/ biopsy analysis in women with HI
HIV-1 infected women/ neoplasia and condylomata in a c
eral blood/HPV DNA in cervical secretion in women in relation to
tamin A deficiency with dysplasia in the Women's Interag
e/Case-control study of cancer and HIV infection in Abidja E
HIV-infected women for intraepithelial neoplasia with seria
t following treatment of intraepithelial neoplasia/Local HI
RT)/Early regression of lesions in HIV-seropositive wome
(HPV) prevalence and dysplasia/Relationship of HIV-1
a/Short term course of squamous intraepithelial lesions (
es in the progression of disease/Trying to know the role of
g antibody, plasma and viral burden in relation to maternal
rauterine device use on shedding of HIV-1 DNA/Effect of i
vera and integrity of the epithelium/Use of the long-acting
/AIDS/HIV viral load in, vaginal and menstrual fluids as c
logical parameters and intraepithelial neoplasia (CIN) in
gonococcal/chlamydial infections at a Ugandan STD clini
ed women/Incidence of dysplasia among HIV-infected wo
al therapy (HAART) on dysplasia and HPV infection amo
Mexico/Pre-malignant lesions (PCL) in HIV+ women in a
si-species in blood and secretions of HIV-1 and HIV-2 infe
Factors associated with chlamydial infection in African wo
s and plasma viral load/ Cervicovaginal HIV-1 RNA levels and pla
ubtype and shedding of cervicovaginal HIV-1 DNA during pregna
16 and 18 in serum and secretions of HIV-infected
ount of HPV 16 DNA in secretions of HIV-infected
ral load, CD4 level and human papillomavirus infe
A and RNA detection in (CV) secretions of asympt
f anti-HIV antibodies in fluid of HIV-seronegative f
c antibody in serum and lavage of HIV+ women/HI
e E/Infection of human cervix with a primary isolate HIV-1 subtype
uptured membranes/ Cesarean section (C/S) is effective in prev
ssion following elective cesarean delivery with zidovudine treatme
ncy virus/A "Bloodless section" and perinatal transmissi
treatment and elective section reduces the vertical tran
eripheral blood CD34+ CFU-Cs in HIV-infected individuals upon c
students in N'Djamena, Chad /Sexual behavior, knowledge of HIV t
ulnerable population/ consumers of alcoholic drinks in drin
to fight against AIDS in: A key element for taking care/The c
ease of HIV epidemic in from 1986 to 1997/THE increase of
ycho-medico support in /The polyvalent AI-Nadjma (the star)
ort/Congenital HIV and Chagas' disease: Case report/Congenital
V patients in Paraguay/ diseases in HIV patients in Parag
high school students in Chaing-mai, Thailand/Changes in HIV rel
acin for the treatment of chancroid /Randomized, double-blind, pla
nt employed children in Chandigarh, North India: Their knowledge
roach for PLWHAs with chemical dependency/Role model of nony hood in preparation of chemiotherapics /Auxiliary cabinet like a
alitis/Microglia secrete chemoattractants affecting monocyte mig
erent genetic subtypes/ Chemokine receptor usage of HIV-1 prima
SIV acute infections/f- responses in bronchoalveolar
iminary meta-analysis/ receptor genotypes and HIV d
V infected individuals/ receptor CCR2b 641 polymorp
n vivo by DNA vaccines/ levels modulated in vivo by D
mphocytes of200/mm3/, chemokine receptor, cytokin
nt analogues of the C-C chemokine RANTES with enhanced HIVctive antagonists of the receptor CXCR4 and potent in
pair deletion in the C-C receptor 5 (CCR5) gene in an
uence of heterozygous receptor 5 mutation on respon
gression/Role of CCR5 receptor gene in vertical HIV-1
CR2, CCR5 and SDF1 variants on clinical and immun
pression/Repertoire of receptor expression in the fem
ncreased expression of co-receptors on mucosal vers
s usage of CC and CXC coreceptors in vivo correlates
and association of CC receptor 5 and focal adhesion
y HIV-1/Involvement of receptors in the induction of int
miquantitation of human mRNAs by reverse transcripti
d assay/Cytokine and assays for IL-2, IFNy, TNFa, a
rapy/Chemokines and receptors expression during c
ansmission/lnduced P/- and cytokine response in preg

ect of HIV-1 infection on receptor expression in CD4+ t
activation markers and receptor 5 (CCR5) genotype i
cyte function/Role of /- s and chemokine receptor on
200/mm3/Chemokine, receptor, cytokine and monoki
ontrols/Cytokine and production by lung and blood c
anti HIV-1 IL-2 therapy/ Chemokines and chemokine receptors ex
virus delivery/Anti-HIV chemokines:Domain mapping and HIV-2

ct---+
32227
22318
32131
60893
60980
13293
621*/22301
622*/22305
22308
22310
22312
22317
22319
22321
23290
23453
23462
23477
32134
80*/33230
60158
60289
60396
60652
60909
42148
13117
22304
624*/22311
22313
23450
23515
31111
21155
23305
23272
23274
23291
12323
23437
34182
60418
60423
60424
12159
60776
13513
22189
60041
12440
22478
21138
9*/11166
11225
13311
13327
42324
60132
11101
57*"/11107
12105
12116
12162
13183
335*/21109
21119
8*/21134
55*/21135
21172
21177
21184
22416
23279

31141
31147
31159
60132
60787
22416
11104

each to private medical:The Nigerian experience/AIDS c 13479
gnosed in urban health in Lusaka, Zambia?/How likely ar 453*/22154
ve primary health care in Nairobi, Kenya, 1993 to 1997/D 22190
n AIDS documentation network to the fight against HIV/AI 33493
ducation in community and at youth groups: Higher level 33534
g people in community and youth clubs in The Netherland 33538
omen attending health, in West Africa/A community-bas 165*/41135
are education in smaller /A collaborative approach to HIV p 42409
tribution in correctional in Ontario, Canada/Inmates' opini 43400
i-inflammatory alkaloid cepharanthine inhibits HIV-1 replication in 60049
gh levels of HIV-RNA in cerebral spinal fluid/Neurological sympto 12195
rophylaxis for PCP and toxoplasmosis be safely disconti 12268
CCR-5A32 deletion on or extracerebral toxoplasmosis o 13184
dictive value of primary lymphoma HIV-related: Update/ 22324
enrolled in clinical trials/ Cerebrospinal fluid HIV-1 RNA levels and 32202
neurological diseases/ fluid (CSF) versus plasma 42170
es/Stavudine entry into cerebrospinal fluid of HIV-infected subject 12355
gh prolactin levels in the fluid of HIV-infected patient 21133
onema pallidum DNA in fluid from HIV patients with 22101
egalovirus (CMV) in the fluid (CSF) of AIDS patient 22262
d: Update/EBV-DNA in fluid (CSF) as predictive val 22324
QV/stavudine (d4T) on fluid (CSF) HIV-RNA levels 32197
etween the viral load in fluid (CSF), plasma and CN 32201
n/Antigen p24 HIV-1 in fluid in patients with neurol 32222
) resistance patterns in fluid (CSF) compartment/E 563*/32284
omplications of HIV and fluid (CSF) polymerase cha 41156
uantification of HIV-1 in fluid/Comparative evaluati 42177
abacavir (1592 U89) in fluid (CSF) using multiple lu 42271
ain reaction (PCR) on fluid (CSF) in patients with 60734